Category Archives: EU Projects

HYPOSENS

HYPOSENS – The Vision of HypoSens is to develop a widely accepted, non-invasive and crucial prognostic tool for breast cancer progression in early stages to help clinicians and specially oncologists to decide about prompt therapy approaches to patients and improve quality of life and expectancy. Our breakthrough research will focus on the development, preclinical and… Read More »

BATCure

The goal of BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases – neuronal ceroid lipofuscinoses (NCL) or Batten disease. There are > thousand affected across Europe, with a combined incidence of c.1:100 000. The NCLs are devastating and debilitating genetic disorders that mainly affect children, who… Read More »

EIT HEALTH

EIT Health is one of the largest healthcare initiatives worldwide. The partnership will promote entrepreneurship and develop innovations in healthy living and active ageing, providing Europe with new opportunities and resources. This will be achieved through delivering products, concepts and services, including educational programmes that will nurture talents and train the workforce of tomorrow. For… Read More »

GLAM

Glass-Laser Mulitplexed Biosensors Differential cancer diagnosis takes place daily in clinical settings for a better monitoring of patient responses to existing treatments. However outcome of this diagnosis is today still poor. Moreover, current technology to measure biomarker levels is expensive and sophisticated. Most cancer biomarker analysis use blood or biological tissues as the main source… Read More »

DENECOR

DeNeCor addresses the diagnosis and treatment of neurological diseases, which have an increased incidence due to the aging society. DeNeCoR develops, tests and demonstrates neuro devices, systems and methods for a diverse set of diagnostic and treatment modalities.   The project addresses the grand challenges of home and Hospital healthcare in the VMS Chapter on… Read More »

NANOTEST

Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics